Ifan Ali Wafa
Overview
Explore the profile of Ifan Ali Wafa including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
80
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wardhana M, Kuntaman K, Utomo B, Aryananda R, Rifdah S, Wafa I, et al.
Yonsei Med J
. 2024 Mar;
65(4):202-209.
PMID: 38515357
Purpose: In view of conflicting reports on the ability of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) to infect placental tissue, this study aimed to further evaluate the impact of inflammation...
2.
Wafa I, Pratama N, Budi D, Sutanto H, Rosyid A, Kencono Wungu C
Acta Med Indones
. 2023 Nov;
55(3):243-254.
PMID: 37915159
Background: The use of monoclonal antibody as the proposed treatment of COVID-19 showed different results in various prior studies, and Efficacy remains open in literature. This study aimed to comprehensively...
3.
Oktavian P, Budi D, Wibowo I, Rusuldi R, Kusumawardhani A, Wafa I, et al.
Diabetes Metab Syndr
. 2023 Aug;
17(9):102847.
PMID: 37639999
Background And Aims: The use of a bionic pancreas with automated insulin delivery systems to prevent complications of diabetes mellitus shows conflicting results. We aimed to comprehensively discuss the potential...
4.
Rejeki P, Witarto B, Witarto A, Rifdah S, Wafa I, Utami D, et al.
J Basic Clin Physiol Pharmacol
. 2023 Mar;
34(3):311-320.
PMID: 36957989
Moderate-to-vigorous physical activity (MVPA) has been shown to have a favorable effect on many diseases as a complementary therapy and is a critical component of healthy living. During the pandemic...
5.
Pratama N, Wafa I, Budi D, Sutanto H, Asmarawati T, Effendi G, et al.
Vaccines (Basel)
. 2022 Dec;
10(12).
PMID: 36560590
Vaccine effectiveness (VE) and the urgency of booster vaccination against SARS-CoV-2 Omicron variant need evaluation. A systematic search was conducted from 1−6 April, 2022. VE difference (VED) estimates were assessed...
6.
Pratama N, Anastasia E, Wardhani N, Budi D, Wafa I, Susilo H, et al.
Diabetes Metab Syndr
. 2022 Oct;
16(10):102636.
PMID: 36240686
Background And Aims: Opioid use in heart failure (HF) management is controversial, and whether rapid symptomatic relief outweighs the risks of opioid use in HF remains unknown. This study aimed...
7.
Susilo H, Pikir B, Thaha M, Alsagaff M, Suryantoro S, Kencono Wungu C, et al.
Genes (Basel)
. 2022 Jul;
13(7).
PMID: 35885904
The association between angiotensin-converting enzyme insertion/deletion (ACE I/D) polymorphisms and plasma ACE levels may allow for the optimization of a preventive intervention to reduce cardiovascular morbidity and mortality in the...
8.
Wafa I, Pratama N, Sofia N, Anastasia E, Konstantin T, Wijaya M, et al.
Diabetes Metab J
. 2022 Mar;
46(2):260-272.
PMID: 35255551
Background: Abrupt implementation of lockdowns during the coronavirus disease 2019 (COVID-19) pandemic affected the management of diabetes mellitus in patients worldwide. Limited access to health facilities and lifestyle changes potentially...
9.
Budi D, Pratama N, Wafa I, Putra M, Wardhana M, Kencono Wungu C
Heliyon
. 2022 Feb;
8(1):e08835.
PMID: 35128114
Objective: The use of remdesivir for pregnant patients with coronavirus disease 2019 (COVID-19) showed conflicting results in prior studies. We aimed to systematically review its efficacy and safety for this...
10.
Pratama N, Wafa I, Budi D, Putra M, Wardhana M, Kencono Wungu C
PLoS One
. 2022 Feb;
17(2):e0261350.
PMID: 35108277
Objective: Pregnancy is a known risk factor for severe Coronavirus disease 2019. It is important to develop safe vaccines that elicit strong maternal and fetal antibody responses. Methods: Registries (ClinicalTrials.gov,...